TTM
27.6%
YoY change
+16.63pp
Trough year (2024)
16.2%
Peak year (2019)
39.0%
Latest annual
32.8%
Operating Margin history chart for AbbVie (ABBV) from 2009 to 2025
Latest: 32.8%
Operating Margin change chart for AbbVie (ABBV) from 2009 to 2025
Latest: +16.63pp
Operating Margin history table for AbbVie (ABBV) from 2009 to 2025
| 2025 | 32.8% | +16.63pp | ||
| 2024 | 16.2% | -7.27pp | ||
| 2023 | 23.5% | -7.72pp | ||
| 2022 | 31.2% | -0.69pp | ||
| 2021 | 31.9% | +7.09pp | ||
| 2020 | 24.8% | -14.22pp | ||
| 2019 | 39.0% | +19.54pp | ||
| 2018 | 19.5% | -14.34pp | ||
| 2017 | 33.8% | -2.60pp | ||
| 2016 | 36.4% | +3.46pp | ||
| 2015 | 33.0% | +15.88pp | ||
| 2014 | 17.1% | -13.05pp | ||
| 2013 | 30.1% | -1.50pp | ||
| 2012 | 31.6% | +10.90pp | ||
| 2011 | 20.8% | -9.41pp | ||
| 2010 | 30.2% | -4.53pp | ||
| 2009 | 34.7% | — |
- 202532.8%+16.63pp
- 202416.2%-7.27pp
- 202323.5%-7.72pp
- 202231.2%-0.69pp
- 202131.9%+7.09pp
- 202024.8%-14.22pp
- 201939.0%+19.54pp
- 201819.5%-14.34pp
- 201733.8%-2.60pp
- 201636.4%+3.46pp
- 201533.0%+15.88pp
- 201417.1%-13.05pp
- 201330.1%-1.50pp
- 201231.6%+10.90pp
- 201120.8%-9.41pp
- 201030.2%-4.53pp
- 200934.7%—
Operating Margin values are taken from AbbVie's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Margin at AbbVie (ABBV)
According to AbbVie's latest reported financial statements, the company's latest reported operating margin is 27.6%. Operating margin is operating income divided by revenue — the share of each sales dollar left after cost of goods sold and operating expenses (SG&A, R&D), but before interest and taxes. It isolates how profitable the core business is before financing and tax decisions, so it is comparable across companies with different capital structures.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, AbbVie (ABBV) reported operating margin of 32.85% – expanded 16.6 percentage points year-over-year.
The record annual operating margin stands at 39.03%, reached in 2019; the historical low of 16.22% was recorded in 2024.
AbbVie Operating Margin by Year
AbbVie Operating Margin 2025: 32.8%
AbbVie operating margin in 2025 was 32.85%, expanded 16.6 percentage points from 2024.
AbbVie Operating Margin 2024: 16.2%
2024's operating margin for AbbVie came in at 16.22%, contracted 7.3 percentage points from 2023. This figure represents the lowest annual value in the available history.
AbbVie Operating Margin 2023: 23.5%
AbbVie posted operating margin of 23.49% in 2023, contracted 7.7 percentage points from 2022.
AbbVie Operating Margin 2022: 31.2%
In 2022, AbbVie reported operating margin of 31.21%, contracted 0.7 percentage points from 2021.
AbbVie Operating Margin 2021: 31.9%
AbbVie operating margin in 2021 was 31.89%.
See more financial history for AbbVie (ABBV).
Sector peers by Operating Margin
Healthcare peers of AbbVie (ABBV), ranked by their latest operating margin
| 45.9% | |
| 45.3% | |
| 31.6% | |
| 27.6% | |
| 26.4% | |
| 23.7% | |
| 17.8% | |
| 4.2% |
- 45.9%
- 45.3%
- 31.6%
- 27.6%
- 23.7%
Frequently asked questions
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation